vs
Side-by-side financial comparison of Diamondback Energy (FANG) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $4.2B, roughly 1.3× Diamondback Energy). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 0.6%, a 7.3% gap on every dollar of revenue. On growth, Diamondback Energy posted the faster year-over-year revenue change (4.7% vs -0.3%).
Diamondback Energy, headquartered in Midland, Texas, is an American company engaged in hydrocarbon exploration in the Permian Basin.
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
FANG vs FMS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.2B | $5.5B |
| Net Profit | $25.0M | $434.2M |
| Gross Margin | — | 27.4% |
| Operating Margin | 2.7% | 11.7% |
| Net Margin | 0.6% | 7.9% |
| Revenue YoY | 4.7% | -0.3% |
| Net Profit YoY | 38.4% | 240.4% |
| EPS (diluted) | $0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $4.2B | — | ||
| Q4 25 | $3.4B | $5.5B | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $4.0B | — | ||
| Q4 24 | $3.7B | $5.5B | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — |
| Q1 26 | $25.0M | — | ||
| Q4 25 | $-1.5B | $434.2M | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $699.0M | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.1B | $127.6M | ||
| Q3 24 | $659.0M | — | ||
| Q2 24 | $837.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 2.7% | — | ||
| Q4 25 | -82.4% | 11.7% | ||
| Q3 25 | 31.5% | — | ||
| Q2 25 | 31.0% | — | ||
| Q1 25 | 41.3% | — | ||
| Q4 24 | 38.0% | 5.1% | ||
| Q3 24 | 26.8% | — | ||
| Q2 24 | 46.6% | — |
| Q1 26 | 0.6% | — | ||
| Q4 25 | -43.2% | 7.9% | ||
| Q3 25 | 25.9% | — | ||
| Q2 25 | 19.0% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 28.9% | 2.3% | ||
| Q3 24 | 24.9% | — | ||
| Q2 24 | 33.7% | — |
| Q1 26 | $0.08 | — | ||
| Q4 25 | $-4.99 | — | ||
| Q3 25 | $3.51 | — | ||
| Q2 25 | $2.38 | — | ||
| Q1 25 | $4.83 | — | ||
| Q4 24 | $3.40 | — | ||
| Q3 24 | $3.19 | — | ||
| Q2 24 | $4.66 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $-174.0M | $1.7B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $42.6B | $15.4B |
| Total Assets | $70.1B | $33.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-174.0M | — | ||
| Q4 25 | $104.0M | $1.7B | ||
| Q3 25 | $159.0M | — | ||
| Q2 25 | $219.0M | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $161.0M | $1.3B | ||
| Q3 24 | $370.0M | — | ||
| Q2 24 | $6.9B | — |
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | — | ||
| Q3 25 | $15.8B | — | ||
| Q2 25 | $15.1B | — | ||
| Q1 25 | $13.0B | — | ||
| Q4 24 | $12.1B | — | ||
| Q3 24 | $11.9B | — | ||
| Q2 24 | $12.0B | — |
| Q1 26 | $42.6B | — | ||
| Q4 25 | $37.0B | $15.4B | ||
| Q3 25 | $39.1B | — | ||
| Q2 25 | $38.9B | — | ||
| Q1 25 | $38.5B | — | ||
| Q4 24 | $37.7B | $17.0B | ||
| Q3 24 | $37.4B | — | ||
| Q2 24 | $17.4B | — |
| Q1 26 | $70.1B | — | ||
| Q4 25 | $71.1B | $33.5B | ||
| Q3 25 | $76.2B | — | ||
| Q2 25 | $71.9B | — | ||
| Q1 25 | $70.1B | — | ||
| Q4 24 | $67.3B | $36.3B | ||
| Q3 24 | $65.7B | — | ||
| Q2 24 | $35.6B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | 0.39× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.69× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8B | $2.9B |
| Free Cash FlowOCF − Capex | $1.7B | — |
| FCF MarginFCF / Revenue | 40.2% | — |
| Capex IntensityCapex / Revenue | 27.9% | — |
| Cash ConversionOCF / Net Profit | 73.12× | 6.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $2.3B | $2.9B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.3B | $2.6B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.5B | — |
| Q1 26 | $1.7B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 40.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 27.9% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 73.12× | — | ||
| Q4 25 | — | 6.67× | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.68× | — | ||
| Q4 24 | 2.18× | 20.20× | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 1.83× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FANG
| Oil, natural gas and natural gas liquid sales | $3.8B | 90% |
| Sales of purchased oil | $385.0M | 9% |
FMS
Segment breakdown not available.
